13 de marzo de 2026

Helicobacter Pylori: Transmission and Clinical Importance

Overview of Helicobacter Pylori

• Helicobacter pylori is a gram-negative, flagellated, microaerophilic bacterium that colonizes the gastric mucosa. It can also be found in other body organs, including saliva.

Transmission Pathways

• The primary transmission route is person-to-person via fecal-oral contact; however, transmission through kissing has not been completely ruled out.

• If one individual is being treated for H. pylori, close contacts should also be screened and potentially treated to prevent reinfection.

Epidemiology and Prevalence

• Over 50% of the global population is affected by H. pylori, with prevalence rates as high as 80-90% in South America due to environmental factors like lack of potable water and sanitation.

Clinical Significance

• H. pylori is the leading cause of chronic gastritis and is associated with gastric ulcers and duodenal ulcers; it is classified as a Group 1 carcinogen by WHO.

Virulence Factors

• Key virulence factors include two toxins: CagA (causes intense inflammation) and VacA (induces epithelial damage), which lead to inflammatory cytokine production in the gastric mucosa.

• The enzyme urease allows H. pylori to survive in acidic environments by creating an alkaline environment that promotes bacterial colonization.

Mechanisms of Damage Induced by H. Pylori

Urease Functionality

• Urease constitutes about 10% of bacterial proteins; it converts urea into ammonia and carbon dioxide, neutralizing gastric acid and increasing local pH for better survival.

Diagnosis Challenges

• Diagnosis often involves rapid urease tests; however, treatment resistance can occur due to various virulence factors making eradication difficult.

Factors Contributing to Treatment Resistance

Complexity of Eradication

• Multiple virulence factors complicate treatment efforts; these include urease activity, flagella presence for mobility, adhesins for strong attachment to gastric mucosa, and toxin production leading to chronic inflammation.

Role of Cytokines

• The bacteria induce pro-inflammatory cytokine production from the host's own gastric mucosa, exacerbating inflammation beyond what the bacteria alone would cause.

CagA's Role in Gastric Cancer Development

Association with Cancer Risk

• CagA-positive strains are linked with increased risk for gastric cancer development; geographic variations exist regarding strain types affecting cancer incidence rates.

Regional Variations

• In East Asia (e.g., Japan), higher rates of CagA-positive strains correlate with elevated stomach cancer risks but also improved early detection techniques have reduced mortality rates over time.

Understanding Gastric Cancer Detection in Peru

Challenges in Early Detection

• In Peru, there is a negative strain of the virulent factor related to gastric cancer, but there are no exact protocols for early detection. Many cases are diagnosed at late stages when treatment options become limited.

Clinical Consequences of Helicobacter Pylori

• Chronic gastritis and peptic ulcers are linked to Helicobacter pylori infection, which can also lead to lymphoma and gastric cancer. The importance of diagnosing this infection is emphasized due to its severe clinical implications.

Diagnostic Tests for Helicobacter Pylori

• There are both non-invasive (e.g., breath tests using carbon isotopes, fecal antigen tests, serology) and invasive methods (e.g., urease test during endoscopy, histological biopsy). Each method has specific applications based on patient history and symptoms.

Limitations of Culturing Helicobacter Pylori

• Culturing H. pylori is complex as it does not grow easily in laboratory settings; thus, PCR and culture methods are reserved for patients who have not responded to multiple eradication therapies. This complicates diagnosis further.

Urease Test: Advantages and Considerations

• The urease test is quick, cost-effective, and boasts over 95% sensitivity and specificity but requires certain conditions (e.g., stopping proton pump inhibitors two weeks prior) to avoid false negatives. Biopsies should be taken from multiple sites due to patchy distribution of the bacteria in the stomach lining.

Helicobacter Pylori Testing and Gastric Cancer Overview

Helicobacter Pylori Testing Methods

• The sensitivity and specificity of the breath test for Helicobacter pylori is 95%. It is crucial to suspend proton pump inhibitors two weeks prior and avoid antibiotics for 30 days to ensure accurate results.

• Serology tests detect specific IGG antibodies against Helicobacter pylori using EISA but are not reliable for confirming eradication, with a sensitivity below 80%. Gastroenterologists typically do not use this method for diagnosis or confirmation.

• Serology is mainly used in large studies assessing prevalence rather than individual patient treatment. For patients presenting with stomach pain, serology would not be recommended due to the likelihood of persistent positive results from past exposure.

• Fecal antigen tests are non-invasive and utilize monoclonal techniques for both diagnosis and confirmation of eradication. They have high sensitivity and specificity exceeding 90%, making them preferable, especially when patients struggle with breath tests.

• Breath tests require strict adherence to instructions; if patients cannot comply, fecal antigen testing is a better alternative. Both methods necessitate stopping proton pump inhibitors two weeks before testing.

Treatment Protocols for Helicobacter Pylori

• Fecal antigen testing can also be useful in monitoring patients who fear reinfection after successful treatment. Reinfection rates are low (under 10%) but can increase due to poor sanitation practices.

• Current guidelines recommend quadruple therapy as the first-line treatment, which includes proton pump inhibitors, bismuth, tetracycline, and metronidazole over a duration of 14 days.

• Confirmation of eradication should occur four weeks post-treatment using either breath or fecal antigen tests while adhering to the same pre-test protocols regarding medication suspension.

Gastric Cancer Epidemiology

• Gastric cancer ranks as the fourth most common cancer globally and is the second leading cause of cancer-related deaths. It predominantly affects men aged between 40 and 70 years old.

• There is a higher incidence in Asia compared to Latin America; however, early detection in Asia leads to more treatable cases versus late-stage diagnoses often seen in Peru.

• Key risk factors include infection with Helicobacter pylori, smoking habits, high-salt diets, family history of gastric cancer, and consumption of ultra-processed foods containing carcinogenic nitrosamines like processed meats.

Cascada de Correa y Cáncer Gástrico

Importancia del Helicobacter pylori

• El Helicobacter pylori es crucial en la progresión de la gastritis crónica a cáncer gástrico, generando inflamación crónica.

Progresión hacia el Cáncer

• La inflamación crónica provoca citocinas proinflamatorias que llevan a atrofia, metaplasia intestinal, displasia y finalmente adenocarcinoma. Factores como tabaquismo, dieta rica en ultraprocesados y antecedentes familiares también contribuyen.

Tipos de Cáncer Gástrico

• El 90-95% de los cánceres gástricos son adenocarcinomas; el resto incluye linfomas gástricos y tumores del estroma gastrointestinal. Según la clasificación de Lauren, hay dos tipos principales: intestinal (más común en hombres) y difuso (predomina en jóvenes).

Características de los Tipos Intestinal y Difuso

• El tipo intestinal está asociado con factores ambientales como dieta y tabaquismo, mientras que el tipo difuso tiene una asociación hereditaria. La localización también varía: el tipo intestinal se encuentra más en el antro del estómago.

Clasificación Endoscópica de Borman

• La clasificación de Borman describe cuatro tipos de adenocarcinomas según su apariencia endoscópica:

• Tipo I: tumor polipoide.

• Tipo II: tumor ulcerado.

• Tipo III: tumor infiltrante.

• Tipo IV: diseminación extensa por todo el estómago.

Diagnóstico del Cáncer Gástrico

• Se diagnostica mediante endoscopía alta con biopsia; la tomografía se utiliza para estadificación. La ecoendoscopía puede ayudar a determinar si es un cáncer gástrico temprano o avanzado.

Estadificación del Cáncer Gástrico

• En la estadificación TNM:

• T indica invasión tumoral (T1A a T4B).

• N representa ganglios afectados.

• M indica presencia o ausencia de metástasis.

Tratamiento Individualizado

• El tratamiento no es uniforme; depende del estadiaje e incluye opciones desde cirugía hasta quimioterapia o cuidados paliativos.

Endoscopic Techniques in Gastric Cancer Management

Overview of Endoscopic Procedures

• The endoscopic approach allows for the resection of early-stage lesions, potentially offering a curative treatment option. In advanced cancer cases, a gastrectomy is typically performed.

• Treatment plans are individualized; options may include chemotherapy or immunotherapy based on patient-specific factors.

Distinction Between Endoscopy and Ecoendoscopy

• Clarification on diagnostic procedures: digestive endoscopy and ecoendoscopy are not the same. High-endoscopy uses a flexible tube with a light source to visualize lesions directly.

• Standard endoscopy involves taking biopsies through an opening in the instrument, primarily used for visualizing stomach lesions.

Understanding Ecoendoscopy

• Ecoendoscopy employs a different device that includes an ultrasound transducer at its tip, allowing internal imaging of stomach layers and adjacent organs like the pancreas.

• This technique is particularly useful for assessing gastric cancer staging—distinguishing between early-stage and more advanced cancers that have invaded deeper layers.

Treatment Approaches Post-Endoscopic Resection

• Confirmation of early gastric cancer via standard endoscopy leads to treatment through this method.

• Following completion of surveys related to attendance, participants can ask questions regarding complications post-resection.

Complications After Gastric Resection

• Complications depend on the type of resection performed (e.g., subtotal vs. radical gastrectomy). Surgical techniques vary based on tumor location within the stomach.

• Potential complications include stenosis at anastomosis sites, which can be treated by balloon dilation during endoscopic procedures if confirmed.

Managing Complications Effectively

• If dilation fails, stenting may be necessary to maintain patency for nutrition. Surgical intervention may be required if these methods do not resolve complications.

• Other possible complications include bleeding from surgical edges and complex issues such as fistulas requiring specialized management strategies.

Understanding Endoscopy and Ecoendoscopy in Gastric Cancer Diagnosis

The Role of Endoscopy in Diagnosing Gastric Lesions

• When performing an endoscopy, if a lesion is identified as Borman 1 but the biopsy results indicate gastritis, it may be due to sampling errors from non-ideal areas.

• Biopsies should ideally be taken from the edges of suspicious lesions to increase diagnostic accuracy; otherwise, a repeat endoscopy may be necessary for better samples.

• If initial biopsies yield negative results or show gastritis, further endoscopic examination is warranted to obtain more accurate biopsies.

Importance of Ecoendoscopy

• Ecoendoscopy is particularly useful for assessing deeper gastric lesions that are not visible through standard endoscopic methods, especially those originating from subepithelial layers.

• While traditional endoscopy aids in initial diagnosis, ecoendoscopy provides critical information about the depth and layer involvement of gastric tumors.

Differentiating Between Early and Advanced Gastric Cancer

• Initial diagnosis via endoscopy is crucial; however, ecoendoscopy becomes essential when early-stage gastric cancer is suspected based on findings like Borman-type lesions.

• For advanced gastric cancer cases identified during endoscopies, a CT scan (tomography) is recommended instead of ecoendoscopy.

Summary of Diagnostic Pathways

• The choice between ecoendoscopy and tomography depends on the stage of gastric cancer: early-stage warrants ecoendoscopic evaluation while advanced stages require imaging through CT scans.